Granahan Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,329
Closed -$272K 243
2017
Q3
$272K Sell
1,329
-196
-13% -$45.6K 0.02% 205
2017
Q2
$371K Buy
1,525
+126
+9% +$29.6K 0.03% 188
2017
Q1
$334K Sell
1,399
-279
-17% -$65K 0.03% 184
2016
Q4
$352K Buy
1,678
+348
+26% +$72.1K 0.01% 196
2016
Q3
$306K Buy
+1,330
New +$325K 0.01% 213

Other funds holding AGN

Granahan Investment Management's AGN Position: Q4 2017 in Review

Granahan Investment Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,329 shares — an estimated $272K sold.

Granahan Investment Management first reported a position in AGN in Q3 2016 and held it in 5 quarters. The position peaked at $371K in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Granahan Investment Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Granahan Investment Management sold 1,329 Allergan plc shares in Q4 2017, an estimated $272K.
  • Granahan Investment Management first reported a position in Allergan plc in Q3 2016 and held it in 5 quarters.
  • Granahan Investment Management's Allergan plc position peaked at $371K in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Granahan Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.